Approaches for Treatment Sequencing in Patients With HER2+ mCRC
In a detailed conversation, Tanios Bekaii-Saab, MD, Daniel Ahn, DO, and Christina Wu, MB, BCh, MD, discuss various scenarios for treating HER2+ metastatic colorectal cancer, focusing on patient profiling, testing methods, and different sequencing strategies including the use of trastuzumab.
Video Player is loading.
Recent Videos
Auto-SCT or CAR T? A Case-Based Discussion in Relapsed DLBCL
Personalizing CAR T: Making the Right Call for Each Patient
Rethinking CAR T Timing: Insights on CAR T Efficacy and Patient Selection
CAR T in the Real World: Clinician Perspectives on Outcomes, Toxicity, and Patient Management
TRANSFORM and ZUMA-7: A Discussion on Efficacy and Safety of CAR T in R/R DLBCL
Tailoring Therapy: Patient-Specific Decision-Making in Relapsed DLBCL
Beyond Salvage: When to Move to CAR T in Relapsed DLBCL
DLBCL in Focus: Transforming Outcomes With CAR T Therapy
Closing Reflection: A Journey of Understanding and Resilience
Patient Voices: Shaping the Future of PNH Care
Related Content
